FDA Approves Selpercatinib for 3 RET-Positive Cancer Types

The FDA approved the first therapy to treat cancers with rearranged during transfection (RET) gene alterations.

Source: CancerNetwork - May 8, 2020 Category: Cancer & Oncology Authors: Kristie L. Kahl Source Type: news